Protective Effect of Melatonin and Omeprazole Against Alendronat-Induced Gastric Damage

Abstract

Alendronate causes serious gastrointestinal adverse effects. We aimed to investigate if free radicals have any role in the damage induced by alendronate and if melatonin or omeprazole is protective against this damage. Rats were administered 20 mg/kg alendronate by gavage for 4 days, either alone or following treatment with melatonin or omeprazole. On the last day, following drug administration, pilor ligation was performed, and 2 hr later rats were killed and stomachs were removed. Gastric acidity and tissue ulcer index values, lipid peroxidation, and myeloperoxidase and glutathione levels, as well as the histologic appearance of the stomach tissues, were determined. Chronic oral administration of alendronate induced significant gastric damage, increasing lipid peroxidation and myeloperoxidase activity, while tissue glutathione levels decreased. Treatment with omeprazole or melatonin prevented this damage as well as the changes in biochemical parameters, and melatonin appeared to be more efficient than omeprazole in protecting the mucosa. Intraperitoneal administration of alendronate did not cause much gastric irritation. Findings of the present study suggest that alendronate induces oxidative gastric damage by a local irritant effect and that melatonin and omeprazole are protective against this damage due to their antioxidant properties.

Protective Effects of Simvastatin Against Alendronate-Induced Gastric Mucosal Injury in Rats

“…ALD is known to significantly increase gastric acidity when administrated orally, and this increased acidity may be owing to the local irritation caused by ALD [47]. At very low pH conditions (pH\2), ALD is in the acid form, which is known to be more irritating than the sodium salt [48].…”

Reactive Oxygen Species and the Hypomotility of the Gall Bladder as Targets for the Treatment of Gallstones with Melatonin: A Review

“…The antioxidant effects of melatonin are certainly in part related to its secondary and tertiary metabolites [74]. The potential utility of melatonin in the treatment of enteric pathology due to its free-radical scavenging effect is well supported by previously published studies [75][76][77][78][79][80][81].…”

Microencapsulation of sodium alendronate reduces drug mucosal damage in rats

“…Adverse effects such as gastroesophageal inflammation and ulceration, esophageal erosions, and gastrointestinal bleeding have been associated with the ability of sodium alendronate to damage the epithelium by topical irritant effects (Lanza, 2003;Sener et al, 2005;Marshall et al, 2006). Patients presenting gastrointestinal problems or esophageal abnormalities such as achalasia ought to avoid the sodium alendronate treatment (Lanza, 2003).…”